SCIG is a purified immunoglobulin that is injected into the subcutaneous (fatty) area under your skin.
It is made from human plasma. SCIG contains antibodies (immunoglobulins) which are found in the blood to help fight bacteria, fungi, and viruses.
It is used with people who have primary immune deficiency (PID) or secondary immune deficiency (usually due to certain cancers). Immune deficiency is a condition in which a person’s natural defense system or immune system does not function properly and is unable to make enough antibodies, leaving them more vulnerable to infections. SCIG replaces these antibodies, making people with immune deficiency less likely to develop an infection.
|Document Name||Date of Original Publication||Date Revised|
|Cuvitru - OnePath Support Enrolment and Consent Form||September 26, 2021||September 26, 2021||Download|
|Hizentra CSL Behring Plus Patient Support Program Enrolment and Consent Form||September 26, 2021||September 28, 2021||Download|
|SCIG - Cuvitru Patient Brochure||September 26, 2021||September 29, 2021||Download|
|SCIG - Hizentra Patient and Doctor Discussion Guide||September 26, 2021||September 29, 2021||Download|
|SCIG - Hizentra Patient Brochure||September 26, 2021||September 29, 2021||Download|
- Transfuse Wisely Poster
- IVIG Dose Calculator – Based on Adjusted Body Weight
- COVID-19 Correspondence
- COVID-19 Resources
- Prenatal Testing and Prevention of Alloimmunization in Mothers of Saskatchewan (PRAMS) Program
- Saskatchewan Transfusion Adverse Event Report Form
- The Strange Case of Penny Allison
- Transfusion Best Practice Recommendations